12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga·05/13/2025 12:10:18

Listen to the news

Gainers

CNS Pharma (NASDAQ:CNSP) shares rose 90.1% to $2.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.7 million.
GlucoTrack (NASDAQ:GCTK) shares increased by 25.15% to $0.19. The market value of their outstanding shares is at $4.7 million.
Xilio Therapeutics (NASDAQ:XLO) shares moved upwards by 23.11% to $0.9. The market value of their outstanding shares is at $46.5 million. The company's, Q1 earnings came out 3 days ago.
Arcturus Therapeutics (NASDAQ:ARCT) shares moved upwards by 21.22% to $14.05. The company's market cap stands at $381.0 million. As per the news, the Q1 earnings report came out yesterday.
Silence Therapeutics (NASDAQ:SLN) shares moved upwards by 11.22% to $4.26. The market value of their outstanding shares is at $201.1 million. As per the news, the Q1 earnings report came out 3 days ago.
Redhill Biopharma (NASDAQ:RDHL) stock rose 10.49% to $2.21. The market value of their outstanding shares is at $3.9 million.

Losers

Polyrizon (NASDAQ:PLRZ) stock declined by 91.8% to $0.03 during Tuesday's pre-market session.
Sangamo Therapeutics (NASDAQ:SGMO) stock decreased by 36.8% to $0.47. The market value of their outstanding shares is at $106.0 million. As per the news, the Q1 earnings report came out yesterday.
Accelerate Diagnostics (NASDAQ:AXDX) stock fell 21.63% to $0.11. The company's market cap stands at $2.6 million.
Klotho Neurosciences (NASDAQ:KLTO) shares declined by 19.73% to $0.14. The market value of their outstanding shares is at $3.9 million.
Coherus BioSciences (NASDAQ:CHRS) stock fell 16.67% to $0.85. The market value of their outstanding shares is at $98.5 million. As per the news, the Q1 earnings report came out yesterday.
Entero Therapeutics (NASDAQ:ENTO) shares decreased by 16.59% to $0.35. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English